- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
May 8th, 2006
NanoNovus: May 8
Jack Uldrich: This article from the Miami Herald provides a good overview of nanotechnology’s ability (and limitations) to detect cancer at an early stage. On the positive side, nanotechnology is leading to the development and creation of new diagnostic technologies that can detect unique “biomarkers”–specific proteins that show up when a cancer is present.
On the down side, these biomarkers are not always either sensitive or specific to a single disease. This suggests that even if new diagnostic technologies are developed, they might not do that much good.
|Related News Press|
Nanotech Grants Options September 22nd, 2016
Arrowhead Pharmaceuticals to Present at Upcoming September Conferences September 1st, 2016
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
The molecular mechanism that blocks membrane receptors has been identified: The work in which the Ikerbasque researcher of the Biofisika Institute Xabier Contreras has participated has been published in the journal Cell October 27th, 2016
Chad Mirkin receives nanotechnology prize in Russia October 26th, 2016